Crohn’s disease: what is it?

Medically reviewed: 15, February 2024

Crohn’s Disease: Causes, Symptoms, Treatment, Self Care

Inflammatory Bowel Diseases (IBD) encompass two main conditions affecting millions worldwide: Crohn’s disease and Ulcerative colitis. This article focuses primarily on understanding Crohn’s disease, its definition, prevalence, and demographic distribution among individuals experiencing its impacts.

Characterized by chronic inflammation within the gastrointestinal tract, Crohn’s disease can occur anywhere along the digestive system lining—from mouth to anus. However, most frequently involved areas comprise the end of the small bowel (the ileum) and colon.

Inflamed patches might extend deeply across several layers of the intestine tissue wall, causing debilitating discomfort accompanied by thickening and scarring over time. Such changes may narrow or even obstruct parts of the gut, leading to serious complications necessitating surgical intervention. Unlike Ulcerative colitis, whose inflammation confines itself to mucosal surfaces, Crohn’s disease affects entire bowel walls, contributing significantly to its unpredictability and severity.

Prevalence and Demographics

The incidence rate of Crohn’s disease varies geographically yet continues rising steadily among developed nations since World War II. Although precise statistics remain uncertain due to inconsistencies in diagnosis methods and reporting procedures, estimates suggest between 3 to 20 cases per 100,000 person-years globally. Moreover, North America reports one of the highest incidences with around 20 new diagnoses annually per every 100,000 inhabitants.

Demographically, Crohn’s disease tends to affect young adults predominantly aged between 15 to 35 years old, though childhood and older adult presentations also emerge occasionally. No single ethnic group evades vulnerability entirely; however, Jewish descendants encounter higher risks than non-Jewish populations across distinct regions.

Furthermore, genetic predisposition seems influential given a positive correlation exists amongst family members sharing similar gene variants increasing susceptibility towards developing Crohn’s disease compared to the general public. Nevertheless, environmental elements trigger initial symptomatic expression, thereby indicating complex etiopathogenesis requiring exhaustive research efforts before complete elucidation.

Causes of Crohn’s Disease

Crohn’s disease isn’t caused by one single thing. Several factors work together to lead someone to get this condition. Let’s take a closer look at four major contributors:

Genetic Factors

One crucial aspect is our DNA. People with certain genetic markers have increased chances of getting Crohn’s disease. For instance, having mutations in the NOD2/CARD15 gene raises the risk quite a bit. However, remember that inheriting these genes doesn’t necessarily mean you’ll definitely get Crohn’s. Many people carry these risky genes without ever showing symptoms.

Environmental Triggers

Our surroundings matter too. Though scientists don’t know precisely which environmental factors flip the switch on Crohn’s disease, there seem to be strong connections with:

• Smoking cigarettes
• Taking particular medications, especially antibiotics and nonsteroidal anti-inflammatory drugs (NSAIDs)
• Experiencing stress and anxiety chronically
• Consuming a diet filled with processed food, sugar, and fat

Staying away from these triggers might decrease the possibility of developing Crohn’s disease.

Microbial Involvement

Bacteria living inside us could add fuel to the fire too. Our gut contains trillions of helpful microorganisms called microbiomes. When something disturbs this delicate balance, potentially harmful bacteria can multiply excessively, irritating the gut lining.

This situation creates fertile ground for inflammation and activates immune responses. Studies indicate that folks dealing with Crohn’s tend to possess distinct types and quantities of gut bacteria compared to healthy people.

Immune System Dysfunction

Finally, problems with how our bodies manage infections and regulate immune responses likely play a part in sparking Crohn’s disease. An improperly managed immune reaction might attack the body’s own tissues rather than focusing solely on foreign invaders. Overactive or confused immune systems might bring on constant inflammation episodes and damage the digestive system.

Here is a more comprehensive explanation.

• Genetic Factors

Although sporadic instances occur without known hereditary links, familial aggregation patterns suggest genetic predispositions play significant roles in determining who develops Crohn’s disease. Specific genes have been identified via linkage studies, particularly NOD2/CARD15 mutations occurring in approximately 10-20% of diagnosed patients.

These variations alter innate immunity functions responsible for detecting bacterial threats and instigating appropriate defensive reactions.

Other implicated candidate loci harbor ATG16L1, IRGM, IL23R, and PTPN2, among others, influencing autophagy regulation, cytokine signaling, or epithelial barrier integrity maintenance. While carrying any of these risk alleles doesn’t guarantee contracting Crohn’s disease outright, it certainly enhances overall susceptibility levels considerably.

• Environmental Triggers

Despite genetic influences setting some boundaries, environmental factors largely drive whether someone ultimately manifests signs of illness.

Epidemiological investigations reveal substantial regional disparities pointing toward lifestyle habits, sanitation standards, socioeconomic statuses, or pollution exposure differentials accounting for variable incidence rates. Evidence indicates smoking doubles odds of acquiring Crohn’s disease and accelerates disease progression once established.

Similarly, high-fat diets, processed foods, refined sugars, emulsifiers, artificial sweeteners, and antibiotics disrupt normal gut flora composition favoring pathogen proliferation linked to aggravated symptoms. Nonetheless, identifying definitive causality remains difficult owing to wide heterogeneity experienced across diverse cohorts subjected to varying combinations of these exposures simultaneously.

• Microbial Involvement

Intensive probiotic research evaluates potential restorative properties provided by beneficial strains attempting to counterbalance damaging perturbations induced otherwise. Meanwhile, fecal microbiota transplantation attempts seek to rectify dysbiosis directly, demonstrating promising albeit still inconclusive results warranting cautious optimism moving forward.

• Immune System Dysfunctions

Proposed explanations posit exaggerated T helper cell subset proportions resulting in exuberant effector outputs alongside insufficient regulatory feedback loops mediated predominantly via CD4^+^CD25^+^FOXP3^+^Tregs and Th17 cells. Apart from adaptive immunological imbalances, innate response defects characterized by neutrophil extracellular trap formation deficiencies, toll-like receptor polymorphisms, or NLRP3 inflammasome irregularities render hosts less adept at controlling invading pathogens escalating insult severity culminating in subsequent relapses despite seemingly adequate treatments administered previously.

Crohn’s Disease Symptoms

When discussing Crohn’s disease, recognizing its signs and symptoms plays a crucial role in receiving timely treatment and improving overall quality of life. Three primary categories summarize them: gastrointestinal symptoms, systemic manifestations, and complications/associated conditions.

Gastrointestinal Symptoms

Most Crohn’s disease sufferers experience noticeable symptoms relating to their gastrointestinal tracts. Some common ones consist of:

1. Diarrhea: Regular loose, watery stools are often reported by people with active Crohn’s disease.
   Stomach pain: Cramping sensations or sharp pangs, mainly centered around the belly button area, appear frequently.
2. Appetite loss: Decreasing interest in food might be attributed to uncomfortable gut feelings or malabsorption issues.
3. Weight loss: Unintentional weight reduction sometimes accompanies diminished hunger and poor nutrition uptake.
4. Blood in stool: Bright red spots or darker tarry stools may raise concerns of inflammation or ulcers in the GI tract.

Other symptoms of Crohn’s Disease

Other than direct gastrointestinal complaints, many individuals struggle with secondary signs originating elsewhere in the body:

• Fatigue: General weariness or lack of energy persists in some people, possibly worsened by iron deficiency anemia derived from intestinal bleeding.
• Fever: Spiking temperatures accompany acute phases of disease activity, suggesting widespread inflammation.
• Skin problems: Various skin lesions crop up infrequently, such as mouth ulcers, hives, or nodules beneath the surface of the skin.
• Eye inflammation: Uveitis, episcleritis, or conjunctivitis might trouble vision and comfort.
• Joint swelling and pain: Arthralgias or arthritides involve peripheral joints like knees, wrists, fingers, or toes, appearing asymmetrically and non-erosive.

Complications of Crohn’s Disease and Associated Conditions

Over time, severe complications or additional health issues might arise from long-term Crohn’s disease:

Nutrient deficiencies: Insufficient calorie, protein, vitamin, or mineral consumption can result from faulty absorption capacity, needing supplementation or enteral feeding assistance.
Obstructions: Partial or complete blockages restrict the smooth passage of intestinal material, sometimes demanding surgery.
Fistulas and abscesses: Abnormal tunneling channels connecting hollow spaces internally might lead to sinus tracts, seeping fluid accumulations, and infected masses.
Colorectal cancer: Enhanced monitoring frequency catches precancerous polyps earlier in this population due to augmented lifetime danger of colorectal carcinoma.
Related disorders: Autoimmune conditions, mental health struggles, or metabolic syndromes coincide somewhat more regularly in people wrestling with Crohn’s disease.

Diagnosing Crohn’s Disease

Accurately diagnosing Crohn’s disease includes several fundamental processes that give healthcare providers enough information to determine the root cause of the presenting symptoms. Typically, the process comprises four integral steps: clinical evaluation, laboratory tests, imaging techniques, and endoscopic examination coupled with biopsy sample collections. By carefully analyzing each stage, physicians gain greater insights into the nature and extent of the condition, ensuring proper treatment planning. Below is a concise overview of each phase:
Clinical Evaluation

Initial clinical assessment consists of gathering comprehensive medical records and performing a systematic physical examination. During this phase, physicians typically explore the following aspects:

Weight fluctuation: Sudden or steady decreases in body weight can be telling signs of underlying medical conditions such as inflammatory bowel disease (IBD), including Crohn’s disease.
Fatigue: Constant weakness, malaise, or diminished energy reserves merits consideration as potential indicators of chronic inflammation.
Abdominal pain: Localized or diffused abdominal discomfort may correlate strongly with gastrointestinal tract affection seen in IBD.
Changes in bowel movements: Increased urgency, consistency, volume, or tenesmus suggests compromised bowel functionality attributable to Crohn’s disease.
Family history: Identifying relatives diagnosed with IBD increases the probability of inheritance and manifestation.

Following attentive case study, healthcare providers proceed to ancillary diagnostic tests.
Laboratory Tests

As part of routine diagnostics, laboratorian specialists execute targeted measurements addressing both quantitative and qualitative variables, supplying instrumental intelligence instrumental in corroborating suspicions or excluding competing possibilities. Examples include:

Blood count: Assessment of complete blood counts (CBC) highlights anemic conditions, leukocytosis, or thrombocytosis, reflecting chronic inflammation found in Crohn’s disease.
Erythrocyte Sedimentation Rate (ESR): Measurements of ESR gauges the degree of inflammation based on settling characteristics of red blood cells in plasma.
C-Reactive Protein (CRP): Quantification of CRP serves as a sensitive marker for detecting active inflammation, although nonspecific.
Fecal Calprotectin: Determination of fecal calprotectin reflects intestinal epithelial injury consequential to local inflammation, thereby differentiating organic IBD from functional bowel disorders.

Collectively, these parameters strengthen the basis for suspected Crohn’s disease, prompting initiation of advanced imaging studies.
Imaging Techniques

Appropriate utilization of modern radiographic technology substantially benefits physicians in delineating structural damages accruing in the alimentary canal. Standard imaging techniques incorporate:

Plain film radiography: Visualizing gross morphological alternations exemplified by bowel obstruction, free air indication, or pneumoperitoneum.
Computed Tomography Enterography (CTE): High-definition volumetric acquisitions capture minute details pertinent to bowel wall thickness, ulcerations, fistulae, or abscesses, decisively discriminating Crohn’s disease from indistinguishable pathologies.
Magnetic Resonance Enterography (MRE): Administering oral or intravenous contrast yields superior soft-tissue contrast enhancement avoiding harmful ionizing radiation employed in CT techniques.

By virtue of their respective advantages, imaging tests allow providers to establish preliminary judgement pending histopathological confirmation.
Endoscopy and Biopsy

Undeniably, endoscopy remains the gold standard modality for definitive validation of presumptive Crohn’s disease, granting access to direct observation of mucosal membranes, securing specimen procurement, and executing therapeutic maneuvers contemporaneously. Subcategories encompass:

Colonoscopy: Direct illumination via optical fiber allows real-time visualization of distal colonic structures extending proximally, ideally traversing the terminal ileum permitting holistic appraisals of involved segments.
Upper Endoscopy: Conducted either esophagogastroduodenoscopy (EGD) or push entero-scope offers complimentary assessment of upper gastrointestinal tract regions typified by skipped lesions rarely detected radiographically.
Biopsy Sampling: Strategically obtained samples serve dual purposes, both consolidating endoscopic observations with corresponding cytopathological attributes and differentiating Crohn’s disease from malignancies, infections, or medication-induced injuries.

Effective Treatment Choices for Crohn’s Disease

Managing Crohn’s disease requires a combination of medical interventions, lifestyle adjustments, and – in severe cases – surgical treatments. This post outlines several treatment avenues that patients and healthcare professionals should consider.
Medical Management
Anti-inflammatory Drugs

Frontline therapy generally begins with aminosalicylates, such as mesalamine and sulfasalazine, to minimize mild-to-moderate inflammation in the gut. They act locally, reducing inflammation and easing symptoms, yet exhibit limited effectiveness in treating aggressive Crohn’s disease.
Corticosteroids

Short term corticosteroid use, such as budesonide and prednisone, targets moderate-to-severe symptoms quickly. Long term usage increases side-effect risks, ranging from bone density loss to glucose metabolism problems. Thus, steroids usually represent temporary relief, allowing concurrent therapies to start working.
Immunomodulators

Modulating the immune system reduces excessive inflammation in Crohn’s disease. Medications such as azathioprine, mercaptopurine, and methotrexate fall into this category. Patients often need months before seeing improvements, but once achieved, they maintain longer remission periods than merely relying on steroids. Potential side-effects include nausea, vomiting, hair loss, and weakened immune response.
Biologic Therapies

Advanced therapy uses genetically engineered proteins inhibiting specific molecules central to inflammatory cascades. Agents like infliximab, adalimumab, vedolizumab, and ustekinumab bind tumor necrosis factor-alpha (anti-TNFα), alpha-4 beta-7 integrin (vedolizumab), or interleukin-12 and interleukin-23 (ustekinumab), inducing and maintaining profound remissions with minimal side-effect profiles. Infusions or injectables normally administer these medicines in controlled settings.
Dietary Modifications

Adjusting one’s diet may influence Crohn’s disease severity by removing trigger foods and incorporating nutrient-rich alternatives. Individual tolerance varies widely, thus keeping track of symptom-provoking meals empowers patients to avoid problematic choices actively. Generally, recommendations steer clear from processed products, saturated fats, alcohol, and caffeine, emphasizing fruits, vegetables, lean proteins, and whole grains. Consultation with registered dietitians familiar with inflammatory bowel diseases expedites successful meal plans.
Surgical Interventions

Surgery appears inevitable for roughly 70% of Crohn’s patients, typically addressing complications like strictures, fistulas, abscesses, or toxic megacolon. Despite restoration of intestinal continuity, recurrence rates hover around 30% after five years and 60% past ten years. Post-surgery management remains imperative to limit complications and maximize longevity of surgical success. Minimally invasive laparoscopic or robotic-assisted surgeries increasingly supplant traditional open operations, hastening recoveries, and minimizing morbidity.

Living with Crohn’s Disease

Living with Crohn’s disease presents numerous day-to-day challenges, but implementing thoughtful routines and embracing emotional flexibility can drastically improve one’s quality of life. In this chapter, we’ll touch upon some essential points for living gracefully with Crohn’s disease.

Establish Support Systems

Building solid connections with friends, family, and support groups can make a world of difference. Share experiences, ask questions, discuss everyday difficulties, and celebrate victories. Feeling understood and heard goes a long way in fostering strength and motivation to overcome setbacks.

Crohn’s Disease Self-Care

Ensure you dedicate time to relaxation, exercise, and good sleep. Practicing yoga, meditation, or mindfulness exercises can greatly benefit mental health and foster a sense of calm. Gentle exercise routines, like walking, swimming, or cycling, can boost energy levels and mood. Getting seven to nine hours of sleep nightly supports overall wellbeing and resiliency during times of stress.

Personalize Your Diet

There’s no universally accepted diet plan for Crohn’s disease, so experimenting with elimination diets may help pinpoint trigger foods. Collaborate with a healthcare provider or dietician experienced in Crohn’s management to identify potential allergens, adopt balanced meal plans, and monitor micronutrient intake. Maintaining hydration is equally important for promoting optimal gastrointestinal function and overall health.

Here’s a list of foods considered relatively safer for people with Crohn’s disease:

1. Lean proteins: Choose fish, chicken, eggs, tofu, tempeh, and lean cuts of meat. Avoid greasy or highly seasoned dishes.
2. Low-fiber fruits and cooked vegetables: Applesauce, bananas, melons, canned fruits, cooked carrots, potatoes without skin, and steamed spinach.
3. White bread, rice, and pasta: Opt for plain varieties without seeds, nuts, or added flavors.
4. Dairy or dairy alternatives: If you’re not lactose intolerant, choose low-fat milk, yogurt, or cheese. Otherwise, select calcium-fortified plant-based milk, such as almond, coconut, rice, or soy milk.
5. Probiotics: Certain fermented foods contain beneficial bacteria, like sauerkraut, kombucha tea, kefir, miso soup, or pickled vegetables. Always introduce probiotics gradually, watching for improvement or deterioration in symptoms.
6. Small, frequent meals: Divide your daily food intake into smaller portions consumed throughout the day. This pattern puts less strain on your digestive system and maintains stable energy levels.

Crohn’s Disease: Key Points in a Nutshell

What is Crohn’s Disease? Crohn’s disease refers to a chronic inflammatory bowel disease (IBD) that can affect any portion of the digestive tract, leading to various uncomfortable symptoms like diarrhea, stomach pain, weight loss, and fatigue.

Who gets Crohn’s Disease? Anyone can develop Crohn’s disease, but it commonly starts in adolescence or early adulthood. There seems to be a genetic factor, with some ethnic groups experiencing higher prevalence rates than others, e.g., Ashkenazi Jews.

Symptoms. Symptoms differ depending on location and severity. However, common ones include abdominal pain, diarrhea, bloody stools, fatigue, loss of appetite, and unintended weight loss. Some individuals may also experience mouth sores or skin and eye inflammation.

Causes. Doctors aren’t completely sure what brings on Crohn’s disease, but theories revolve around genetics, the immune system, and environmental factors. Both inherited traits and external aspects (such as diet, stress, and tobacco use) may interact with immune responses and increase the chance of developing this condition.

Diagnosis. Diagnostic procedures combine clinical evaluation, laboratory tests, imaging techniques, and endoscopy and biopsy. Physicians review medical history and perform physical examinations, order blood tests and stool samples, recommend MRIs, CT scans, or X-rays, and conduct endoscopies with tissue sampling for conclusive results.

Treatment. At present, there’s no permanent cure for Crohn’s disease. Goals focus on symptom management, maintaining remission, and preventing complications. Available treatments span medical management (including anti-inflammatory drugs, corticosteroids, immunomodulators, and biologic therapies), dietary modifications, and surgical interventions.

References:

• Petagna, L., Antonelli, A., Ganini, C., Bellato, V., Campanelli, M., Divizia, A., Efrati, C., Franceschilli, M., Guida, A.M., Ingallinella, S., Montagnese, F., Sensi, B., Siragusa, L. and Sica, G.S., 2020. Pathophysiology of Crohn’s disease inflammation and recurrence. Biology Direct, 15(1), p.23.
• Iglay, K., Bennett, D., Kappelman, M.D., Thai, S., Aldridge, M., Karki, C. and Cook, S.F., 2022. A systematic review of the patient burden of Crohn’s disease-related rectovaginal and anovaginal fistulas. BMC Gastroenterology, 22(1), p.36.
• Rubin, D.T., Ananthakrishnan, A.N., Siegel, C.A., Sauer, B.G. and Long, M.D., 2021. Management of Crohn Disease: A Review. JAMA, 325(4), pp.382-394.
• Torres, J., Mehandru, S., Colombel, J.F. and Peyrin-Biroulet, L., 2017. Crohn’s disease. The Lancet, 389(10080), pp.1741-1755.
• Gomollón, F., Dignass, A., Annese, V., Tilg, H., Van Assche, G., Lindsay, J.O., Peyrin-Biroulet, L., Cullen, G.J., Daperno, M., Kucharzik, T., Rieder, F., Almer, S., Armuzzi, A., Harbord, M., Langhorst, J., Sans, M., Chowers, Y., Fiorino, G., Juillerat, P., Mantzaris, G.J., Rizzello, F., Vavricka, S. and Gionchetti, P., 2017. 3rd European evidence-based consensus on the diagnosis and management of Crohn’s disease 2016: part 1: diagnosis and medical management. Journal of Crohn’s and Colitis, 11(1), pp.3-25.
• Ng, S.C., Shi, H.Y., Hamidi, N., Underwood, F.E., Tang, W., Benchimol, E.I., Panaccione, R., Ghosh, S., Wu, J.C.Y., Chan, F.K.L., Sung, J.J.Y. and Kaplan, G.G., 2018. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. The Lancet, 390(10114), pp.2769-2778.
• Khor, B., Gardet, A. and Xavier, R.J., 2011. Genetics and pathogenesis of inflammatory bowel disease. Nature, 474(7351), pp.307-317. [8]Harvard Health Publishing, 2014. Crohn’s disease. Harvard Health.